Digital Repository

Randomized placebo-controlled trial of the efficacy of mebendazole polymorphs in the treatment of hookworm infections

Show simple item record Gunawardena, N.K. Kumarendran, B. Manamperi, N.H. Senarathna, B.P. Silva, M. Pathmeswaran, A. de Silva, N.R. 2016-05-31T05:06:06Z 2016-05-31T05:06:06Z 2013
dc.identifier.citation The Bulletin of the Sri Lanka College of Microbiologists. 2013; 11(1): 12 en_US
dc.identifier.issn 1391-930x
dc.description Oral Presentation (OP 02) The bulletin of the Sri Lanka College of Microbiologists, 24rd-26th July 2013, Colombo en_US
dc.description.abstract INTRODUCTION: Mebendazole has three polymorphic forms, identified as A, B and C. Animal studies and one previous study in humans have suggested that unlike polymorph C, polymorph A is ineffective in the treatment of hookworm and whipworm infections. OBJECTIVES: A randomized double-blind, placebo-controlled trial was carried out to compare the efficacy of single dose 500 mg tablets of pure mebendazole polymorph C with those containing a 1:1 mixture of polymorphs Aand C, for the treatment of hookworm infections. . DESIGN, SETTING AND METHODS: All eligible individuals living in 219 households in 8 estate divisions in Ratnapura District known to have a high prevalence of hookworm, were recruited after obtaining written, informed consent. A single faecal sample was obtained and examined the same day, using the Kato-Katz technique for quantification of intestinal nematode infections. Those who were found infected with hook¬worms were randomized to one of three treatment arms and requested to provide a second faecal sample 10-14 days after treatment. This was examined in the same manner as the first. RESULTS: A total of 892 individuals were recruited; 601 provided faecal samples; 214 were found positive for hookworm infection; 70, 74 and 70 individuals were randomized to treatment arms A (mixture of polymorphs A and C), B (pure polymorph C) and C (placebo) respectively. Follow-up faeca! samples were provided by 53,48 and 49 persons respectively in each treatment arm. The cure rates in the three treatment arms were 28.3%, 18.8% and 16.3% respectively; they were not significantly different from one another. Comparison of faecal egg count reductions (FECR) in the 3 treatment arms (86.1%, 84.5% and -6.6% in arms A, B and C respectively) showed that both mebendazole formulations performed significantly better than placebo, but there was no statistically significant difference between FECR with the two drug formulations. CONCLUSIONS: A single SOOmg dose of mebendazole, either as Polymorph C alone, or as a mixture of Polymorphs A and C, has little efficacy in curing hookworm infections. However, both formulations are significantly better than placebo in reducing the intensity of infection, with no statistically significant difference between the two formulations. en_US
dc.language.iso en_US en_US
dc.publisher Sri Lanka College of Microbiologists en_US
dc.subject mebendazole polymorphs en_US
dc.title Randomized placebo-controlled trial of the efficacy of mebendazole polymorphs in the treatment of hookworm infections en_US
dc.type Article en_US

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

  • Conference Papers
    Papers presented at local and international conferences by the Staff of the Faculty of Medicine

Show simple item record

Search Digital Repository


My Account